Is KNTE or SCHD a better dividend investment in 2026?

KNTE currently yields 75.47% with a 5% 5-year dividend growth rate. SCHD yields 3.44% with 13.05% growth. The better choice depends on your goal: KNTE offers higher current income.

What is the dividend yield difference between KNTE and SCHD?

KNTE has a forward dividend yield of 75.47% ($2.00/share annually). SCHD yields 3.44% ($1.06/share annually). The yield gap is 72.03 percentage points.

Home › Compare › KNTE vs SCHD

KNTE vs SCHD: Dividend Comparison 2026

KNTE yields 75.47% · SCHD yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KNTE wins by $1.32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

KNTE

● Live price

75.47%

Share price

$2.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.35M

Annual income

$375,142.22

Full KNTE calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.44%

Share price

$30.68

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$422.61

Full SCHD calculator →

Portfolio growth — KNTE vs SCHD

📍 KNTE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KNTE	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KNTE + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KNTE pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KNTE

Annual income on $10K today (after 15% tax)

$6,415.09/yr

After 10yr DRIP, annual income (after tax)

$318,870.89/yr

SCHD

Annual income on $10K today (after 15% tax)

$292.49/yr

After 10yr DRIP, annual income (after tax)

$359.22/yr

At 15% tax rate, KNTE beats the other by $318,511.67/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KNTE + SCHD for your $10,000?

KNTE: 50%SCHD: 50%

100% SCHD50/50100% KNTE

Portfolio after 10yr

$691.0K

Annual income

$187,782.41/yr

Blended yield

27.18%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on KNTE right now

KNTE

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$30.00

+1032.1% upside vs current

Range: $30.00 — $30.00

Altman Z

1.0

Piotroski

2/9

SCHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KNTE buys

SCHD buys

No recent congressional trades found for KNTE or SCHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKNTESCHD

Forward yield	75.47% ✓	3.44%
Annual dividend / share	$2.00 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.35M	$29.0K ✓
Annual income after 10y	$375,142.22 ✓	$422.61
Total dividends collected	$1.17M	$3.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: KNTE vs SCHD ($10,000, DRIP)

Year	KNTE Portfolio	KNTE Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$18,247	$7,547.17	$11,224	$344.10	+$7.0K → KNTE
2	$32,395	$12,870.51	$12,567	$354.98	+$19.8K → KNTE
3	$56,017	$21,354.74	$14,038	$365.30	+$42.0K → KNTE
4	$94,449	$34,510.84	$15,648	$375.06	+$78.8K → KNTE
5	$155,442	$54,381.15	$17,410	$384.27	+$138.0K → KNTE
6	$249,967	$83,643.80	$19,335	$392.95	+$230.6K → KNTE
7	$393,173	$125,708.24	$21,437	$401.10	+$371.7K → KNTE
8	$605,486	$184,791.09	$23,733	$408.75	+$581.8K → KNTE
9	$913,831	$265,960.98	$26,237	$415.91	+$887.6K → KNTE
10	$1,352,941	$375,142.22	$28,968	$422.61	+$1.32M → KNTE

KNTE vs SCHD: Complete Analysis 2026

KNTE — Stock

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.

Full KNTE Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this KNTE vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KNTE vs JEPI KNTE vs O KNTE vs KO KNTE vs MAIN KNTE vs VYM KNTE vs DGRO KNTE vs VIG KNTE vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.